This list is an analysis based on recent market events. It's not an investment recommendation.
About
Chongqing Sansheng Industrial Co.,Ltd. is a Chinese enterprise specializing in the research, development, production, and sale of a diverse range of products, spanning both building materials and chemicals, as well as pharmaceuticals. Within its building materials and chemical segment, the company supplies essential construction inputs such as commercial concrete, water-reducing agents, and expansion agents. These products find extensive application across various large-scale infrastructure projects, including industrial and residential buildings, highways, railways, bridges, tunnels, airports, and water conservancy facilities. Additionally, Sansheng Industrial manufactures sulfuric acid, a key chemical component vital for the production of chemical fertilizers, general industrial chemicals, light industry products, textiles, steel, and water reducer formulations, among other non-fertilizer acidic compounds. The company also maintains a significant presence in the pharmaceutical sector. Its offerings here encompass pharmaceutical intermediates, exemplified by procaine hydrochloride, cefoxitin intermediate, chloramphenicol intermediate, aztreonam intermediate, and orlistat intermediate, which are crucial precursors for antibiotic drugs, anti-hepatitis C treatments, diabetes medications, specific penicillin variants, and cosmetic formulations. Furthermore, Sansheng produces active pharmaceutical ingredients (APIs) such as acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benoate, and diphenhydramine hydrochloride. Its range of finished pharmaceutical preparations includes compound paracetamol diphenhydramine, clarithromycin sustained-release, diclofenac sodium enteric-coated, and famotidine tablets, designed for diverse therapeutic applications like antipyretic and analgesic effects, antiviral, antibacterial, cough relief, allergy management, and local anesthesia. Beyond these, the company provides a selection of clinically significant drugs, including famotidine, diclofenac sodium, nifedipine, acetaminophen, furosemide, and norfloxacin. Established in 2002, the company was initially known as Chongqing Sansheng Special Building Materials Co., Ltd. before officially adopting its current name, Chongqing Sansheng Industrial Co.,Ltd., in October 2016. Its operations are headquartered in Chongqing, China.
What is Chongqing Jiheng pharmaceutical. stock price today?▼
The current price of 002742.SZ is ¥3.36 CNY — it has decreased by -1.18% in the past 24 hours. Watch Chongqing Jiheng pharmaceutical. stock price performance more closely on the chart.
What is Chongqing Jiheng pharmaceutical. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Shenzhen Stock Exchange exchange Chongqing Jiheng pharmaceutical. stocks are traded under the ticker 002742.SZ.
Is Chongqing Jiheng pharmaceutical. stock price growing?▼
002742.SZ stock has fallen by -2.61% compared to the previous week, the month change is a -19.23% fall, over the last year Chongqing Jiheng pharmaceutical. has showed a -31.57% decrease.
What is Chongqing Jiheng pharmaceutical. market cap?▼
Today Chongqing Jiheng pharmaceutical. has the market capitalization of 2.3B
What is Chongqing Jiheng pharmaceutical. revenue for the last year?▼
Chongqing Jiheng pharmaceutical. revenue for the last year amounts to 866.49M CNY.
What is Chongqing Jiheng pharmaceutical. net income for the last year?▼
002742.SZ net income for the last year is -419.68M CNY.
Does Chongqing Jiheng pharmaceutical. pay dividends?▼
Yes, 002742.SZ dividends are paid annual. The last dividend per share was 0.04 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Chongqing Jiheng pharmaceutical. have?▼
As of November 3, 2026, the company has 979 employees.
In which sector is Chongqing Jiheng pharmaceutical. located?▼
Chongqing Jiheng pharmaceutical. operates in the Health & Wellness sector.
When did Chongqing Jiheng pharmaceutical. complete a stock split?▼
The last stock split for Chongqing Jiheng pharmaceutical. was on September 8, 2017 with a ratio of 1:1.
Where is Chongqing Jiheng pharmaceutical. headquartered?▼
Chongqing Jiheng pharmaceutical. is headquartered in Chongqing, China.